$50 for your first 3 months Get the print edition and steer from crisis to recovery
Add this topic to your myFT Digest for news straight to your inbox
Companies say they will submit shot for approval in US and EU within days
Groups including CanSino look to developing markets to gain edge
Shares in Walgreens and CVS hit as ecommerce giant offers huge discounts on prescription drugs
Lossmaking biotech aims to prove doubters wrong after patent probes and controversy over stock sales
Billionaire investor’s Berkshire Hathaway put $5.7bn into four US pharma stocks in Q3
Second set of positive results in a week boosts hope vaccines will be effective
Covid-19 jab may represent proof of concept for other treatments made by the group
Medical professionals argue GPs should lead distribution of vaccines when they are approved for use
Vulnerable companies should not expect a return to business as usual
Video consultations could provide employees with cheaper, faster access to mental health treatment
Jab is third experimental inoculation to enter late-stage trials in country
Facilities with capacity to process 600,000 diagnostic checks a day set for Midlands and Scotland
Doctor leading response warns against high-risk situations such as drinking parties
Government and citizens must discuss how to allocate anti-Covid remedies
The husband and wife team behind the German company are pioneers in a technology that could transform medicine
Kate Bingham praised for securing access to one of the world’s largest portfolios of coronavirus vaccines
Medical freezer suppliers spy an opportunity
Companies and governments must work on prevention as much as treatment
NHS Providers warns hundreds of thousands of patients could be at risk
Big companies were reluctant to pursue a jab, then the commercial calculation changed
Procurement comes amid global vaccine race and is latest sign of cosiness with Moscow
US expert optimistic for Moderna vaccine ‘identical in many respects’ to Pfizer-BioNTech jab
UK Edition
